Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$71.4M |
| 2 |
Merck
MRK
|
+$69M |
| 3 |
Caterpillar
CAT
|
+$65.2M |
| 4 |
Cardinal Health
CAH
|
+$61.3M |
| 5 |
American Airlines Group
AAL
|
+$40.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$54.6M |
| 2 |
CA
CA, Inc.
CA
|
+$48.3M |
| 3 |
Ameren
AEE
|
+$46.3M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$35.9M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$34.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.71% |
| 2 | Healthcare | 13.53% |
| 3 | Technology | 12.95% |
| 4 | Industrials | 11.24% |
| 5 | Energy | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMED
2601
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $531K | ﹤0.01% |
22,765
+10,220
| +81% | +$252K |
|
2602
LGI Homes
LGIH
$1.3B
| $530K | ﹤0.01% |
29,014
+7,740
| +36% | +$128K |
|
2603
Pacific Biosciences
PACB
$441M
| $530K | ﹤0.01% |
85,600
| – | – |
|
2604
McEwen Inc
MUX
$1.07B
| $527K | ﹤0.01% |
18,268
-4,211
| -19% | -$102K |
|
|
BCOV
2605
DELISTED
Brightcove, Inc.
BCOV
| $526K | ﹤0.01% |
49,900
+9,800
| +24% | +$90.5K |
|
|
RVNC
2606
DELISTED
Revance Therapeutics, Inc.
RVNC
| $525K | ﹤0.01% |
+15,428
| New | +$483K |
|
|
LEAF
2607
DELISTED
Leaf Group Ltd.
LEAF
| $525K | ﹤0.01% |
54,862
-290
| -0.5% | -$2.54K |
|
|
CAS
2608
DELISTED
A M Castle & Co
CAS
| $525K | ﹤0.01% |
47,526
-31,285
| -40% | -$394K |
|
2609
First Community Bankshares
FCBC
$904M
| $521K | ﹤0.01% |
36,315
-240
| -0.7% | -$3.55K |
|
|
VMEM
2610
DELISTED
VIOLIN MEMORY, INC.
VMEM
| $521K | ﹤0.01% |
29,400
+20,975
| +249% | +$315K |
|
|
ACRE
2611
Ares Commercial Real Estate
ACRE
$236M
| $520K | ﹤0.01% |
41,900
+11,400
| +37% | +$144K |
|
|
TAT
2612
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $519K | ﹤0.01% |
45,538
+32,944
| +262% | +$300K |
|
|
LBMH
2613
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $518K | ﹤0.01% |
137,940
+46,200
| +50% | +$180K |
|
|
BIRT
2614
DELISTED
Actuate Corp
BIRT
| $515K | ﹤0.01% |
107,914
-22,853
| -17% | -$112K |
|
|
CZZ
2615
DELISTED
Cosan Limited
CZZ
| $514K | ﹤0.01% |
+37,899
| New | +$482K |
|
|
RALY
2616
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $514K | ﹤0.01% |
47,195
+26,476
| +128% | +$330K |
|
|
TPH
2617
DELISTED
Tri Pointe Homes
TPH
| $513K | ﹤0.01% |
32,577
-208
| -0.6% | -$3.36K |
|
|
UNIS
2618
DELISTED
Unilife Corporation
UNIS
| $513K | ﹤0.01% |
17,310
| – | – |
|
|
SGK
2619
DELISTED
SCHAWK INC CL-A
SGK
| $511K | ﹤0.01% |
25,079
-144
| -0.6% | -$2.9K |
|
|
MRIN
2620
DELISTED
Marin Software
MRIN
| $509K | ﹤0.01% |
1,029
+605
| +143% | +$258K |
|
|
CDI
2621
DELISTED
CDI Corp.
CDI
| $507K | ﹤0.01% |
35,178
-208
| -0.6% | -$3.13K |
|
|
RST
2622
DELISTED
ROSETTA STONE INC
RST
| $506K | ﹤0.01% |
52,042
-8,120
| -13% | -$84.8K |
|
2623
NWPX Infrastructure Inc
NWPX
$1.23B
| $505K | ﹤0.01% |
12,500
-3,300
| -21% | -$120K |
|
2624
Applied Optoelectronics
AAOI
$8.84B
| $504K | ﹤0.01% |
+21,700
| New | +$465K |
|
2625
Ceco Environmental
CECO
$3.99B
| $502K | ﹤0.01% |
32,152
+6,600
| +26% | +$101K |
|
Similar funds
Charles Schwab's Q2 2014 Portfolio in Review
As of Q2 2014, Charles Schwab held 3,240 positions worth $59.5B, up 6.6% from $55.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab's Q2 2014 filing shows 172 new, 1,725 increased, 966 reduced and 151 closed positions. Its largest new stake was Navient: 923,423 shares worth $16.4M. The largest sale was Boeing, an estimated $54.6M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
- Charles Schwab's largest Q2 2014 buy was Navient: 923,423 shares worth $16.4M.
- Charles Schwab added most to Citigroup in Q2 2014, an estimated $71.4M increase.
- Charles Schwab's biggest Q2 2014 reduction was Boeing, cutting an estimated $54.6M.
- Charles Schwab fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $29.8M.
- Charles Schwab's ten largest holdings make up 14% of its $59.5B portfolio in Q2 2014.
- Charles Schwab opened 172 new positions and closed 151 in Q2 2014.
- Charles Schwab's portfolio value rose 6.6% quarter-over-quarter to $59.5B.
Based on Charles Schwab's 13F filing for Q2 2014, filed 30 Jul 2014.